BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 9271425)

  • 1. A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development.
    Qu CK; Shi ZQ; Shen R; Tsai FY; Orkin SH; Feng GS
    Mol Cell Biol; 1997 Sep; 17(9):5499-507. PubMed ID: 9271425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation.
    Qu CK; Feng GS
    Oncogene; 1998 Jul; 17(4):433-9. PubMed ID: 9696036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic evidence that Shp-2 tyrosine phosphatase is a signal enhancer of the epidermal growth factor receptor in mammals.
    Qu CK; Yu WM; Azzarelli B; Feng GS
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8528-33. PubMed ID: 10411909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Shp-2 tyrosine phosphatase has opposite effects in mediating the activation of extracellular signal-regulated and c-Jun NH2-terminal mitogen-activated protein kinases.
    Shi ZQ; Lu W; Feng GS
    J Biol Chem; 1998 Feb; 273(9):4904-8. PubMed ID: 9478933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
    J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.
    Saxton TM; Henkemeyer M; Gasca S; Shen R; Rossi DJ; Shalaby F; Feng GS; Pawson T
    EMBO J; 1997 May; 16(9):2352-64. PubMed ID: 9171349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.
    Ward AC; Oomen SP; Smith L; Gits J; van Leeuwen D; Soede-Bobok AA; Erpelinck-Verschueren CA; Yi T; Touw IP
    Leukemia; 2000 Jul; 14(7):1284-91. PubMed ID: 10914554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells.
    Qu CK; Yu WM; Azzarelli B; Cooper S; Broxmeyer HE; Feng GS
    Mol Cell Biol; 1998 Oct; 18(10):6075-82. PubMed ID: 9742124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation.
    Takada T; Matozaki T; Takeda H; Fukunaga K; Noguchi T; Fujioka Y; Okazaki I; Tsuda M; Yamao T; Ochi F; Kasuga M
    J Biol Chem; 1998 Apr; 273(15):9234-42. PubMed ID: 9535915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common requirement for the catalytic activity and both SH2 domains of SHP-2 in mitogen-activated protein (MAP) kinase activation by the ErbB family of receptors. A specific role for SHP-2 in map, but not c-Jun amino-terminal kinase activation.
    Deb TB; Wong L; Salomon DS; Zhou G; Dixon JE; Gutkind JS; Thompson SA; Johnson GR
    J Biol Chem; 1998 Jul; 273(27):16643-6. PubMed ID: 9642214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
    Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1.
    Dong Q; Siminovitch KA; Fialkow L; Fukushima T; Downey GP
    J Immunol; 1999 Mar; 162(6):3220-30. PubMed ID: 10092773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
    Nakamura K; Brauweiler A; Cambier JC
    J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses.
    Yang W; Tabrizi M; Berrada K; Yi T
    Blood; 1998 May; 91(10):3746-55. PubMed ID: 9573011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
    Lowin-Kropf B; Kunz B; Beermann F; Held W
    J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells.
    Mizuno K; Katagiri T; Hasegawa K; Ogimoto M; Yakura H
    J Exp Med; 1996 Aug; 184(2):457-63. PubMed ID: 8760799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-gamma-stimulated activation of STAT transcription factors in HeLa cells.
    You M; Zhao Z
    J Biol Chem; 1997 Sep; 272(37):23376-81. PubMed ID: 9287352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the hematopoietic cell phosphatase (Hcph) gene is associated with resistance to gamma-irradiation-induced apoptosis in Src homology protein tyrosine phosphatase (SHP)-1-deficient "motheaten" mutant mice.
    Hsu HC; Shultz LD; Su X; Shi J; Yang PA; Relyea MJ; Zhang HG; Mountz JD
    J Immunol; 2001 Jan; 166(2):772-80. PubMed ID: 11145649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences.
    Matthews RJ; Bowne DB; Flores E; Thomas ML
    Mol Cell Biol; 1992 May; 12(5):2396-405. PubMed ID: 1373816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.